About 1 result found for searched term "1362509-93-0" (0.127 seconds)
Cat.No. | Name | Target |
---|---|---|
M24629 | Idarucizumab | Others |
BI 655075 | ||
Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.